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Background: Piper nigrum L. (Piperaceae) is employed in traditional medicine of many countries as analgesic,
antiinflammatory, anticonvulsant, antioxidant, antidepressant and cognitive-enhancing agent. This study was
undertaken in order to evaluate the possible anxiolytic, antidepressant and antioxidant properties of the methanolic
extract of Piper nigrum fruits in beta-amyloid (1–42) rat model of Alzheimer’s disease.
Methods: The anxiolytic- and antidepressant-like effects of the methanolic extract were studied by means of in vivo
(elevated plus-maze and forced swimming tests) approaches. Also, the antioxidant activity in the amygdala was
assessed using superoxide dismutase, glutathione peroxidase and catalase specific activities, the total content of the
reduced glutathione, protein carbonyl and malondialdehyde levels. Statistical analyses were performed using one-way
analysis of variance (ANOVA). Significant differences were determined by Tukey’s post hoc test. F values for which
p < 0.05 were regarded as statistically significant. Pearson’s correlation coefficient and regression analysis were used in
order to evaluate the connection between behavioral measures, the antioxidant defence and lipid peroxidation.
Results: The beta-amyloid (1–42)-treated rats exhibited the following: decrease of the exploratory activity, the percentage
of the time spent and the number of entries in the open arm within elevated plus-maze test and decrease of swimming
time and increase of immobility time within forced swimming test. Administration of the methanolic extract significantly
exhibited anxiolytic- and antidepressant-like effects and also antioxidant potential.
Conclusions: Taken together, our results suggest that the methanolic extract ameliorates beta-amyloid (1–42)-induced
anxiety and depression by attenuation of the oxidative stress in the rat amygdala.
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Alzheimer’s disease (AD) is a multifaceted neurode-
generative disorder of the central nervous system cha-
racterized by progressive cognitive dysfunction [1,2]. It
is known that excessive accumulation of neurotoxic
β-amyloid peptide (Aβ) in the brain is the hallmark of
AD and the deposition of Aβ causes neuropathological
lesions in the brain of patients with AD [3].* Correspondence: hritcu@uaic.ro; jaursnoumedem@yahoo.com
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unless otherwise stated.These patients often exhibit psychiatric symptoms
along with cognitive decline [4]. Emotional symptoms
like anxiety and phobia contribute significantly to the
clinical profile in mild cognitive impairment (MCI) and
AD [5,6]. Emotional behavior critically depends on the
amygdala, a region of the temporal lobe that is affected
by Aβ and neurofibrillary tangle pathology at early stages
of AD [7,8]. Intraneuronal Aβ accumulation in the
amygdala enhanced fear and anxiety in AD transgenic
mice [9]. Moreover, Aβ accumulation in the basolateral
amygdala also contributed to an increase in anxiety in
AD transgenic mice [10]. Previously published data
suggest that oxidative stress is involved in Aβ (1–42)-This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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It has been shown that the involvement of free radicals
in AD includes the presence of elevated levels of protein
oxidation, lipid peroxidation products and oxidative
damage to mitochondria due to the ability of the Aβ
peptide to act as a pro-oxidant. All of these data suggest
that the oxidation process clearly unleashes AD [12].
Anxiety and depression increase the severity of cogni-
tive decline in AD patients [4]. Anxiety is more common
in individuals with dementia than in individuals without
dementia [13] and it is associated with worse quality of
life, problem behaviors, limitations in activities of daily
living, nighttime awakenings and poorer neuropsycho-
logical performance, even after controlling for depres-
sion [13]. Depression is one of the most prevalent and
life-time threatening forms of mental illnesses, whereas
AD is a neurodegenerative disorder that affects more
than 37 million people worldwide. Recent studies have
highlighted a strong relationship between depression
and AD [14].
Dietary supplements have been extensively studied for
their beneficial effects on cognition and AD neuropa-
thology and may thus represent a safe, natural treatment
for AD [15].
Piper nigrum L. (Piperaceae) is one of the most popular
spice products in oriental countries (mostly in Southeast
Asia) [16]. It has been traditionally used for the treatment
of malaria in India and the epilepsy in China [17]. More-
over, the fruits of P. nigrum have been widely used for
thousands of years in household spices as condiment, as
well as for the treatment of cholera and dyspepsia and
other gastric ailments and arthritic disorders [18].
Piperine, a major alkaloid of black pepper (P. nigrum
L.) used extensively as condiment and flavoring for all
types of savory dishes [19], also presents analgesic, anti-
inflammatory, anticonvulsant, antioxidant, antidepres-
sant and cognitive-enhancing effects [20]. It has been
shown that piperine protects against neurodegeneration
and cognitive impairment in animal model of cognitive
deficit like condition of AD [21]. Furthermore, in a re-
cent study we were able to show that the methanolic ex-
tract of P. nigrum fruits ameliorated Aβ (1–42)-induced
spatial memory impairment by attenuation the oxidative
stress in the rat hippocampus [2]. Moreover, this may be
one of the reasons that this extract could also exert
anxiolytic and antidepressant activities.
In this study we examined the effects of the methanolic
extract of P. nigrum fruits on anxiety and depression levels,
as well as the importance of the methanolic extract in oxi-
dative stress status in the amygdala of Aβ (1–42)-treated
rats. Correlation between the anxiety-depression-like be-
haviors and the levels of the main oxidative stress markers
from the amygdala of Aβ (1–42)-treated rats, as a result of
the methanolic extract administration was also investigated.Methods
Plant material and plant extract
Piper nigrum fruits were collected in Dschang, West
Region of Cameroon in June 2010 and identified by Victor
Nana at the National Herbarium Yaoundé where a vou-
cher specimen was registered and deposited (No. 25818/
SFRcam). The air dried and powdered sample (1 kg) was
extracted with methanol for 48 h at room temperature.
The extract was then filtered and concentrated under re-
duced pressure to give the crude extract and kept at 4°C
until further investigations.
HPLC (LC/DAD) analysis
To identify the main compounds an Agilent 1200 HPLC
system (Agilent Technologies, CA, USA) coupled with
DAD detector was used. The working conditions were:
Agilent Zorbax Eclipse XDB-C18 column (4.6 × 150 mm,
5 μm); column temperature: 20°C; detection wavelengths:
240, 282, 326, 340 and 521 nm; flow rate: 0.6 mL/min; gra-
dient elution: formic acid 0.1% (solvent A) and acetonitrile
(solvent B); the initial conditions were 100% A and 0% B;
the gradient program was 5-30-70-90% solvent B at 5-20-
30-45 min, after which we switched back to the initial
conditions 5 min; sample injection (25 μL of 40 mg/mL
dry extract in methanol: water, 7:3).
Animals
The study used 60 male Wistar rats (3 months old)
weighing 250 ± 50 g at the start of the experiment.
The animals were housed in a temperature and light-
controlled room (22°C, a 12-h cycle starting at 08:00 h)
and were fed and allowed to drink water ad libitum.
Animals used in this study were treated in accordance
with the guidelines of the animal bioethics of the Act on
Animal Experimentation and Animal Health and Welfare
from Romania and all procedures were in compliance with
Directive 2010/63/EU of the European Parliament and of
the Council of 22 September 2010 on the protection of
animals used for scientific purposes. The protocol was
approved by the Committee on the Ethics of Animal Ex-
periments of the Alexandru Ioan Cuza University of Iasi
(Permit Number: 1502721). All surgery was performed
under sodium pentobarbital anesthesia, and all efforts
were made to minimize animal suffering and to reduce
the number of animal used.
Neurosurgery
All surgical procedures were conducted under aseptic con-
ditions, under sodium pentobarbital (50 mg/kg b.w., i.p.,
Sigma-Aldrich, Germany) anesthesia. Rats were mounted
in the stereotaxic apparatus with the nose oriented 11°
below horizontal zero plane. Animal model of AD was
established by intracerebroventricular (i.c.v.) injection of
400 pmol Aβ (1–42) (beta-amyloid peptide 1–42, Rat,
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of the methanolic extract according to the procedure
established by Laursen and Belknap [22]. Aβ (1–42) was
administered right-unilaterally through Hamilton syringe
over 4 min, and the syringe was left in place for 5 min after
injection before being slowly removed. The injection vol-
ume (4 μL) was delivered gradually (1 μL/min) using the
following coordinates: 1.5 mm lateral to the midline;
7.4 mm ventral to the surface of the cortex [23]. The
sham-operated rats were injected with saline.
Drug administration
The rats were divided into 6 groups (10 animals per
group): (1) Control group (sham-operated) received dis-
tilled water treatment; (2) Aβ (1–42) alone-treated group
received diazepam (DZP, 1.5 mg/kg) treatment; (3) Aβ
(1–42) alone-treated group received tramadol (TRM,
10 mg/kg) treatment; (4) Aβ (1–42) alone-treated group
received distilled water treatment; (5) Aβ (1–42)-treated
group received 50 mg/kg of the methanolic extract of
P. nigrum fruits treatment (Aβ (1–42) + P50); (6) Aβ
(1–42)-treated group received 100 mg/kg of the methanolic
extract of P. nigrum fruits treatment (Aβ (1–42) + P100).
The methanolic extract of P. nigrum fruits was dissolved
in distillated water. The administration of the distilled
water and the methanolic extract was performed by gas-
tric gavage with biomedical needles (length 7.62 cm, ball
diameter 4 mm, straight). The volume administered was
10 mL/kg of body weight, daily, for 21 consecutive days
after neurosurgery. Moreover, animals received extract
treatment during training in elevated plus-maze and forced
swimming tests. Diazepam hydrochloride (Sigma-Aldrich,
Germany) and tramadol (Sigma-Aldrich, Germany) were
used as positive controls and were injected intraperitone-
ally (i.p.) in a volume of 1 mL/kg in laboratory rats, 1 h
before behaviorally tested. The estimated daily dose of
piperine administered to rats was 46 mg for the group re-
ceived 50 mg/kg of the methanolic extract treatment and




Behavior in the elevated plus-maze (EPM) is also utilized
to assess exploration, anxiety, and motor behavior. The
EPM consists of four arms, 49 cm long and 10 cm wide,
elevated 50 cm above the ground. Two arms were
enclosed by walls 30 cm high and the other two arms
were exposed. 30 min after the administration of the
methanolic extract of P. nigrum fruits, each rat was
placed in the center of the maze facing one closed arm.
Behavior was observed for 5 min., and the time spent
and number of entries into the open and enclosed arms
was counted [24]. The percentages of time spent in theopen arms (time spent in the open arms/time spent in
all arms x 100) were calculated. In addition, the total
number of open- and enclosed-arm entries (number of
crossing), which indicates the exploratory activity of ani-
mals [25], was measured. An entry was defined as an
animal placing all four paws into an arm, and no time
was recorded when the animal was in the central area.
The maze floor was cleaned with cotton and 10% etha-
nol solution between subjects.
Forced swimming test (FST)
The FST is the most widely used model for assessing
depressive-like response [26]. The depressive-like re-
sponse was assessed, basically using the same method
described by Campos [27], but with modification. On
the first day of the experiments (pretest session), rats
were individually placed into cylindrical recipients
(diameter 30 cm, height 59 cm) containing 25 cm of
water at 26 ± 1°C. The animals were left to swim for
15 min before being removed, dried and returned to
their cages. The procedure was repeated 24 h later, in a
6 min swim session (test session), 30 min after the ad-
ministration of the methanolic extract of P. nigrum
fruits. During the test session, the following behavioral
responses were recorded: (1) immobility (time spent
floating with the minimal movements to keep the head
above the water); and (2) swimming (time spent with ac-
tive swimming movements).
Biochemical parameter assay
After behavioral tests, all rats were deeply anesthetized
(using sodium pentobarbital, 100 mg/kg b.w., i.p.,
Sigma-Aldrich, Germany), decapitated and whole brains
were removed. Bilateral amygdala was carefully excised.
Each of the amygdala samples were weighted and ho-
mogenized (1:10) with Potter Homogenizer coupled with
Cole-Parmer Servodyne Mixer in ice-cold 0.1 M potas-
sium phosphate buffer (pH 7.4), 1.15% KCl. The homo-
genate was centrifuged (15 min at 960 × g) and the
supernatant was used for assays of SOD, GPX, CAT spe-
cific activities, total content of reduced GSH, protein
carbonyl and MDA levels.
Determination of SOD activity
The activity of superoxide dismutase (SOD, EC 1.15.1.1)
was assayed by monitoring its ability to inhibit the photo-
chemical reduction of nitroblue tetrazolium (NBT). Each
1.5 mL reaction mixture contained 100 mM TRIS/HCl
(pH 7.8), 75 mM NBT, 2 μM riboflavin, 6 mM EDTA, and
200 μL of supernatant. Monitoring the increase in absor-
bance at 560 nm followed the production of blue forma-
zan. One unit of SOD is defined as the quantity required
to inhibit the rate of NBT reduction by 50% as previously
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expressed as units/mg protein.
Determination of GPX activity
Glutathione peroxidase (GPX, E.C. 1.11.1.9) activity was
analyzed by a spectrophotometric assay. A reaction mix-
ture consisting of 1 mL of 0.4 M phosphate buffer
(pH 7.0) containing 0.4 mM EDTA, 1 mL of 5 mM
NaN3, 1 mL of 4 mM glutathione (GSH), and 200 μL of
supernatant was pre-incubated at 37°C for 5 min. Then
1 mL of 4 mM H2O2 was added and incubated at 37°C
for further 5 min. The excess amount of GSH was quan-
tified by the DTNB method as previously described by
Sharma and Gupta [29]. One unit of GPX is defined
as the amount of enzyme required to oxidize 1 nmol
GSH/min. The enzyme activity is expressed as units/mg
protein.
Determination of CAT activity
Catalase (CAT, EC 1.11.1.6) activity was assayed follo-
wing the method of Sinha [30]. The reaction mixture
consisted of 150 μL phosphate buffer (0.01 M, pH 7.0),
100 μL supernatant. Reaction was started by adding
250 μL H2O2 0.16 M, incubated at 37°C for 1 min and
reaction was stopped by addition of 1.0 mL of dichro-
mate: acetic acid reagent. The tubes were immediately
kept in a boiling water bath for 15 min and the green
colour developed during the reaction was read at
570 nm on a spectrophotometer. Control tubes, devoid
of enzyme, were also processed in parallel. The enzyme
activity is expressed as μmol of H2O2 consumed/min/mg
protein.
Total content of reduced GSH
Glutathione (GSH) was measured following the method
of Fukuzawa and Tokumura [31]. Samples were de-
proteinized by the addition of 5% end concentration
5-sulfosalicylic acid and centrifugation at 20800 × g for
30 min. 200 μL of supernatant was added to 1.1 mL of
0.25 M sodium phosphate buffer (pH 7.4) followed by
the addition of 130 μL DTNB 0.04%. Finally, the mixture
was brought to a final volume of 1.5 mL with distilled
water and absorbance was read in a spectrophotometer
at 412 nm and results were expressed as μg GSH/μg
protein.
Determination of protein carbonyl level
The extent of protein oxidation in the amygdala was
assessed by measuring the content of protein carbonyl
groups, using 2,4-dinitrophenylhydrazine (DNPH) deri-
vatization as described by Oliver [32] and following the
indications of Luo and Wehr [33]. Basically, the super-
natant fraction was divided into two equal aliquots
containing approximately 2 mg of protein each. Bothaliquots were precipitated with 10% trichloroacetic acid
(TCA, w/v, final concentration). One sample was treated
with 2 N HCl, and the other sample was treated with an
equal volume of 0.2% (w/v) DNPH in 2 N HCI. Both
samples were incubated at 25°C and stirred at 5 min in-
tervals. The samples were then reprecipitated with 10%
TCA (final concentration) and subsequently extracted
with ethanol-ethyl acetate (1:1, v/v) and then reprecipi-
tated at 10% TCA. The pellets were carefully drained
and dissolved in 8 M urea with 20 mM sodium phos-
phate buffer, pH 6.5. Insoluble debris was removed by
centrifugation at 13 000 × g at 4°C. The absorbance at
370 nm of the DNPH-treated sample versus the HCl
control was recorded, and the results are expressed as
nmols of DNPH incorporated/mg of protein based on
an average absorptivity of 21.0 mM−1 cm−1 for most ali-
phatic hydrazones.
Determination of MDA level
Malondialdehyde (MDA), which is an indicator of lipid
peroxidation, was spectrophotometrically measured by
using the thiobarbituric acid assay as previously described
by Ohkawa [34]. 200 μL of supernatant was added and
briefly mixed with 1 mL of 50% trichloroacetic acid in
0.1 M HCl and 1 mL of 26 mM thiobarbituric acid. After
vortex mixing, samples were maintained at 95°C for
20 min. Afterwards, samples were centrifuged at 960 × g
for 10 min and supernatants were read at 532 nm. A cali-
bration curve was constructed using MDA as standard
and the results were expressed as nmol/mg protein.
Estimation of protein concentration
Estimation of protein was done using a bicinchoninic
acid (BCA) protein assay kit (Sigma-Aldrich, Germany).
The BCA protein assay is a detergent-compatible formu-
lation based on BCA for the colorimetric detection and
quantification of total protein, as previously described by
Smith [35].
DNA fragmentation
Total DNA was isolated from the amygdala samples
using the phenol/chloroform method as previously
described by Ausubel [36]. 50 mg tissue sample was
digested overnight at 37°C in 0.6 mL digestion buffer
(100 mM NaCl, 10 mM TRIS/HCl, 25 mM EDTA
pH 8.00, 0.5% SDS) containing 0.1 mg/mL proteinase K
(Boehringer Mannheim, Germany). The digest was ex-
tracted with equal volumes of TRIS-saturated phenol
(pH 8.0) (Roti-phenol, Roth, Germany) by shaking gently
to completely mix the two phases. The phases were then
separated by centrifugation and the aqueous phase
(approx. 0.6 mL) was transferred to another tube avoi-
ding interphase. The DNA was then precipitated by
adding 300 μL of 7.5 M ammonium acetate (i.e., 1/2 of
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temperature and shaken gently to mix thoroughly. DNA
seen as stringy precipitate was pelleted by centrifugation
and washed with 70% ethanol to remove traces of so-
dium dodecyl sulfate and phenol. After removing etha-
nol, DNA was air-dried for 10 min at room temperature
and suspended with 50 μL of 10 mM TRIS (pH 8.0),
1 mM EDTA. DNA content was determined spectro-
photometrically by absorbance at 260 nm and the purity
of the DNA was confirmed by a ratio > 1.8 at 260/
280 nm. Approximately 0.5 mg genomic DNA was dis-
solved in a mixture of 10 μL of TRIS-EDTA and 5 μL of
gel loading buffer (0.25% bromophenol blue, 0.25%
xylene cyanol FF, 30% (v/v) glycerol) and then loaded on
a 1.5% agarose gel in TRIS-boric acid-EDTA (TBE)
buffer (89 mM Tris boric acid, 2 mM EDTA, pH 8.0).
Electrophoresis was performed in TBE at 120 V until
sufficient resolution was obtained. A 1-kb DNA ladder
(New England Biolabs, Ipswich, MA) was used as a
standard size marker. The bands were visualized by
ethidium bromide staining under UV light.
Statistics
Behavioral scores within elevated plus-maze and forced
swimming tests and biochemical data were analyzed by
one-way analysis of variance (ANOVA) using GraphPad
Prism 6 for Windows. All results are expressed as mean +
S.E.M. F values for which p < 0.05 were regarded as statis-
tically significant. Significant differences were determined
by Tukey’s post hoc test. Pearson’s correlation coefficient
and regression analysis were used in order to evaluate the
connection between behavioral measures, the antioxidant
defence and lipid peroxidation.
Results
Chemical composition of Piper nigrum extract
Fourth peak (RT 28.945 min) is represented by piperine,
one of the major compounds found in general in pepper
species (Figure 1). The purity factor indicates that the peak
contains piperine almost 90%. The quantity in our extract
is higher than that of other similar amines. The amount of
piperine in 1 mg methanolic extract was 0.917 mg. TheFigure 1 HPLC data for piperine isolated from the Piper nigrum fruitsexperiment was in triplicate and the calculated amounts
represent the average yield (SD ± 0.0001). Our results are
in accordance to literature data for other Piper species
(P. nigrum, P. guineense and P. tuberculatum) [37].
Effect of Piper nigrum extract on elevated plus-maze
behavior
As can be seen in Figure 2a, in the elevated plus-maze task
ANOVA revealed a significant overall differences between
all groups (F(4,45) = 13.38, p < 0.0001) on the percentage of
the time spent in the open arms. Both doses of the metha-
nolic extract, but especially 100 mg/kg, significantly in-
creased the percentage of the time spent in the open arms
in Aβ (1–42)-treated groups as compared to Aβ (1–42)
alone-treated group. Additionally, Tukey’s post hoc ana-
lysis revealed a significant difference between Aβ (1–42)
vs. Aβ (1–42) + P50 groups (p < 0.01) and Aβ (1–42) vs.
Aβ (1–42) + P100 groups (p < 0.0001).
As can be seen in Figure 2b, in the elevated plus-maze
task ANOVA revealed a significant overall differences
between all groups (F(4,45) = 32.06, p < 0.0001) on the
number of open-arm entries. The administration of the
methanolic extract, especially 50 mg/kg, significantly in-
creased on the number of open-arm entries of Aβ (1–42)-
treated groups as compared to Aβ (1–42) alone-treated
group. Additionally, Tukey’s post hoc analysis revealed a
significant difference between Aβ (1–42) vs. Aβ (1–42) +
P50 groups (p < 0.001).
As can be seen in Figure 2c, in the elevated plus-maze
task ANOVA revealed a significant overall differences bet-
ween all groups (F(4,45) = 27.92, p < 0.0001) on the num-
ber of crossing (exploratory activity). The administration
of the methanolic extract, but especially 100 mg/kg, sig-
nificantly increased the number of crossing of Aβ (1–42)-
treated groups as compared to Aβ(1–42) alone-treated
group. Additionally, Tukey’s post hoc analysis revealed a
significant difference Aβ (1–42) vs. Aβ (1–42) + P100
groups (p < 0.001).
The diazepam treatment significantly increased the
percentage of the time spent in the open arms, the num-
ber of open-arm entries and the number of crossing as
compared to Aβ (1–42)-alone-treated group.extract.
Figure 2 Effects of the methanolic extract of Piper nigrum fruits (50 and 100 mg/kg) in the elevated plus-maze test on the percentage
of the time spent in the open arms (a), the number of open-arm entries (b) and the number of crossing (c) in the Aβ (1–42)-treated
rats. Values are means + S.E.M. (n = 10 animals per group). For Turkey’s post hoc analysis - #Aβ (1–42) vs. Aβ (1–42) + P50: p < 0.01 and ##Aβ (1–42)
vs. Aβ (1–42) + P100: p < 0.0001 (a), #Aβ (1–42) vs. Aβ (1–42) + P50: p < 0.001 (b) and ##Aβ (1–42) vs. Aβ (1–42) + P100: p < 0.001 (c).
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swimming test
In the forced swimming test, ANOVA revealed a significant
overall differences between all groups on the swimming
time (F(4,45) = 14.07, p < 0.0001) (Figure 3a) and on the im-
mobility time (F(4,45) = 14.33, p < 0.0001) (Figure 3b). Both
doses of the methanolic extract, but especially 50 mg/kg,
significantly increased swimming time and decreased im-
mobility time of Aβ (1–42)-treated groups as compared to
Aβ (1–42) alone-treated group. Additionally, Tukey’s post
hoc analysis revealed a significant difference between Aβ
(1–42) vs. Aβ (1–42) + P50 groups (p < 0.0001) and Aβ
(1–42) vs. Aβ (1–42) + P100 groups (p < 0.001) for the
swimming time and between the Aβ (1–42) vs. Aβ (1–42) +
P50 groups (p < 0.001) and Aβ (1–42) vs. Aβ (1–42) +
P100 groups (p < 0.01) for the imobility time.
The tramadol treatment increased the swimming time
and decreased the immobility time as compared to Aβ
(1–42)-alone-treated group.Effect of Piper nigrum extract on SOD, GPX and CAT
activities
For SOD, GPX and CAT specific activities estimated in
the rat amygdala homogenates, ANOVA revealed a sig-
nificant overall differences between all groups for SOD
(F(3,36) = 20.54, p < 0.0001) (Figure 4a), GPX (F(3, 36) =
66.48, p < 0.0001) (Figure 4b) and CAT (F(3, 36) = 12.77,
p < 0.0001) (Figure 4c) specific activities. Both doses of the
methanolic extract, but especially 100 mg/kg, significantly
decreased the specific activities of SOD, GPX and CAT of
Aβ (1–42)-treated groups as compared to Aβ (1–42)
alone-treated group. Additionally, Tukey’s post hoc ana-
lysis revealed significant differences between Aβ (1–42)
and Aβ (1–42) + P50 groups (p < 0.0001) and Aβ (1–42)
and Aβ (1–42) + P100 groups (p < 0.0001) for SOD spe-
cific activity, between Aβ(1–42) and Aβ (1–42) + P50
groups (p < 0.0001) and Aβ (1–42) and Aβ (1–42) + P100
groups (p < 0.0001) for GPX specific activity and bet-
ween Aβ (1–42) + P50 groups (p < 0.0001), Aβ (1–42)
Figure 3 Effects of the methanolic extract of Piper nigrum fruits (50 and 100 mg/kg) on swimming time (a) and immobility time (b) in
the Aβ (1–42)-treated rats during the 6 min period in the forced swimming test. Values are means + S.E.M. (n = 10 animals per group). For
Turkey’s post hoc analysis - #Aβ (1–42) vs. Aβ (1–42) + P50: p < 0.0001 and ##Aβ (1–42) vs. Aβ (1–42) + P100: p < 0.001 (a), #Aβ (1–42) vs. Aβ (1–42) + P50:
p < 0.001 and ##Aβ (1–42) vs. Aβ (1–42) + P100: p < 0.01 (b).
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cific activity.
Effect of Piper nigrum extract on total content of reduced
GSH, protein carbonyl and MDA levels
For the total content of reduced GSH, protein carbonyl
and MDA levels estimated in the rat amygdala homoge-
nates, ANOVA revealed significant overall differences
between all groups for reduced GSH content (F(3, 36) =
14.64, p < 0.0001) (Figure 4d), protein carbonyl level
(F(3, 36) = 22.44, p < 0.00001) (Figure 4e) and MDA level
(F(3, 36) = 17.49, p < 0.0001) (Figure 4f ). Both doses of
the methanolic extract, but especially 100 mg/kg, signifi-
cantly increased the total content of reduced GSH and
MDA level of Aβ (1–42)-treated groups as compared to
Aβ(1–42) alone-treated group. Also, the administration
of the methanolic extract (50 mg/kg) in Aβ (1–42)-
treated group significantly decreased protein carbonyl
level of Aβ (1–42)-treated group as compared to Aβ (1–42)
alone-treated group. Additionally, Tukey’s post hoc analysis
revealed significant differences between Aβ (1–42) and Aβ
(1–42) + P100 groups (p < 0.01) for the total content of re-
duced GSH, between Aβ (1–42) and Aβ (1–42) + P50
groups (p < 0.0001) and Aβ (1–42) and Aβ (1–42) + P100
groups (p < 0.0001) for protein carbonyl level and between
Aβ (1–42) and Aβ (1–42) + P50 groups (p < 0.0001) and
Aβ (1–42) and Aβ(1–42) + P100 groups (p < 0.0001) for
MDA level.
These results support the hypothesis that the metha-
nolic extract of P. nigrum fruits may have induced a de-
crease in neuronal oxidative stress.
More importantly, when linear regression was deter-
mined, significant correlations between the percentage
of the time spent in the open arms vs. MDA (n = 40,
r = −0.662, p < 0.0001) (Figure 5a), swimming time vs.MDA (n = 40, r = −0.608, p < 0.0001) (Figure 5b) and im-
mobility time vs. MDA (n = 40, r = 0.571, p < 0.0001)
(Figure 5c) were evidenced. Additionally, a significant
correlation was evidenced by determination of the linear
regression between SOD vs. MDA (n = 40, r = 0.565,
p < 0.0001) (Figure 5d), GPX vs. MDA (n = 40, r = −0.728,
p < 0.0001) (Figure 5e), CAT vs. MDA (n = 40, r = 0.890,
p < 0.0001) (Figure 5f) and protein carbonyl vs. MDA
(n = 40, r = 0.973, p < 0.0001) (Figure 5g).
These data suggest that anxiolytic and antidepressant
responses within elevated plus-maze and forced swim-
ming test and increase of the antioxidant defence along
with decrease of lipid peroxidation and protein oxidation
could related with the involvement of the methanolic ex-
tract of P. nigrum fruits in neuroprotection against Aβ
(1–42)-induced neuronal oxidative stress generation.
Effect of Piper nigrum extract on DNA fragmentation
In our study, DNA cleavage patterns were absent in the
methanolic extract groups (Figure 6), suggesting that the
methanolic extract of P. nigrum fruits protects against
neurotoxicity and this effect could be related to its anti-
oxidant activity.
Discussion
The present study was aimed to examine the anxiety-
like behavior and depressive-like response following ad-
ministration of the methanolic extract of P. nigrum fruits
rats in subjected to i.c.v. injection of Aβ (1–42). Conse-
quently, i.c.v. injection of Aβ (1–42) causes anxiety-like
behavior and depressive-like response, in accordance
with previous investigations [9,10].
The HPLC analysis indicated piperine as the main
component of our methanolic extract suggesting that
this could be the main constituent responsible for the
Figure 4 Effects of the methanolic extract of Piper nigrum fruits (50 and 100 mg/kg) on SOD (a), GPX (b) and CAT (c) specific activities,
on total content of reduced GSH (d), protein carbonyl (e) and MDA (f) levels in the Aβ (1–42)-treated rats. Values are means + S.E.M.
(n = 10 animals per group). For Turkey’s post hoc analysis - #Aβ (1–42) vs. Aβ (1–42)+P50: p<0.0001 and ##Aβ (1–42) vs. Aβ (1–42)+P100: p<0.0001 (a),
#Aβ (1–42) vs. Aβ (1–42)+P50: p<0.0001 and ##Aβ (1–42) vs. Aβ (1–42)+P100: p<0.0001 (b), #Aβ (1–42) and Aβ (1–42)+P50 groups (p<0.001) and ##Aβ
(1–42) vs. Aβ (1–42)+P100: p<0.0001(c), ##Aβ (1–42) vs. Aβ (1–42)+P100: p<0.01 (d), #Aβ (1–42) vs. Aβ (1–42)+P50: p<0.0001 and ##Aβ (1–42) vs. Aβ (1–
42)+P100: p<0.0001 (e) and #Aβ (1–42) vs. Aβ (1–42)+P50: p<0.0001 and ##Aβ (1–42) vs. Aβ (1–42)+P100: p<0.0001 (f).
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treated rats. It has been reported that piperine inhibited
monoamine oxidase activity, increased monoamine neuro-
transmitters levels, and thus produced antidepressant-like
activity in various mouse models of behavioral despair
[38]. The antidepressive effect of piperine has been also
observed in mice exposed to chronic mild stress and it
was linked to up-regulation of hippocampal progenitorcell proliferation [19]. This antidepressant-like effect of
piperine in chronically stressed mice was also shown to
be mediated by brain-derived neurotrophic factor sig-
naling [39].
Neuropsychiatric symptoms appear in AD patients
which range from abnormal motor behavior, depression
and anxiety and personality alterations such as aggres-
sion and irritability [40]. The elevated plus-maze is
Figure 5 Pearson’s correlation between the percentage of the time spent in the open arms vs. MDA (a), swimming time vs. MDA (b),
immobility time vs. MDA (c), SOD vs. MDA (d), GPX vs. MDA (e), CAT vs. MDA (f) and protein carbonyl vs. MDA (g) in control group (●),
Aβ (1–42) alone treated-group (■), Aβ (1–42) + P50 group (♦) and Aβ (1–42) + P100 group (▲).
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Figure 6 Effects of the methanolic extract of Piper nigrum fruits
(50 and 100 mg/kg) on DNA fragmentation by agarose (1.5%)
gel electrophoresis. Lane 1: DNA ladder; lane 2: control group; lane
3: Aβ (1–42) alone-treated group; lane 4: Aβ (1–42) + P50 group and
lane 5: Aβ (1–42) + P100 group.
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or anxiogenic-like effects of drugs in rodents [41].
As shown in Figure 2a and Figure 2b, the percentage
of the time spent in the open arms and the number of
open-arm entries of Aβ (1–42)-treated rats were sig-
nificantly decreased. This indicates that the Aβ (1–42)-
treated rats experienced high levels of anxiety and were
suitable for evaluating the presumed anxiolytic sub-
stances [24]. Furthermore, after the administration of the
methanolic extract, the time spent in the open arms of Aβ
(1–42)-treated rats significantly increased in a dose-
dependent manner. The number of open-arm entries of
Aβ (1–42)-treated rats increased in the Aβ (1–42) + P50group as compared to the Aβ (1–42)-alone treated group.
Additionally, the exploratory activity of Aβ (1–42)-treated
rats as evidenced by number of crossing (Figure 2c) sig-
nificantly increased after administration of the methanolic
extract, especially in the Aβ (1–42) + P100 group as com-
pared to the Aβ (1–42)-alone treated group. These results
are strengthened by the fact that the benzodiazepine DZP,
well-known as positive standard anxiolytic [42], was used
as positive control comparatively to the methanolic ex-
tract in all of our experimental conditions.
The anxiety indicators in the elevated plus-maze (the
percentage of the time spent in the open arms and the
number of open-arm entries) showed up being sensitive
to the agents which were thought to act via the GABAA
receptor complex [43]. The therapeutic action of the
benzodiazepines and other pharmacological compounds
used to treat anxiety, panic, insomnia, and epilepsy is
mediated by an enhancement of GABAergic neuronal
inhibition through GABAA receptors [44,45]. Moreover,
it is reported that piperine modulates γ-aminobutyric
acid (GABA) type A (GABAA) receptors and exhibited
antidepressant activity in rodents [46,47]. In light with
these reports, our high-piperine containing methanolic
extract have increased anxiolytic-like behavior and ex-
ploratory activity in Aβ (1–42)-treated rats.
The forced swimming test has been validated as a suit-
able tool for predicting the antidepressant properties of
drugs [48]. When rodents are forced to swim in a con-
fined space, after an initial period of struggling, they
would become immobile, resembling a state of despair
and mental depression. This inescapable stressful situa-
tion can be evaluated by assessing different behavioral
strategies [49].
As shown in Figure 3a and Figure 3b, the swimming
time decreased and the immobility time increased in Aβ
(1–42) alone-treated group as compared to control. This
indicates that the Aβ (1–42)-treated rats experienced
more depressive-like behavior. Next, after being given
the methanolic extract, orally for 21 consecutive days,
the swimming time significantly increased, especially in
the Aβ (1–42) + P50 group as compared to the Aβ (1–42)
alone-treated group. We also observed a significant de-
crease in the immobility time of the methanolic extract
treated rats, especially in Aβ (1–42) + P50 group, as com-
pared to Aβ (1–42) alone-treated group.
These results suggest an antidepressant-like effect of
the methanolic extract in response to an inescapable
stress. We used tramadol as a positive control in the
methanolic extract assay for all of our experimental
conditions. Tramadol has been studied in the forced
swimming test in rats, a test developed to predict the
antidepressant action of drugs [50].
Oxidative stress is also involved in the mechanism of
Aβ-induced neurotoxicity [51,52] and AD pathogenesis
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tein oxidation and the formation of hydrogen peroxide
in cultured cells [53]. Similarly, the increases in lipid
peroxidation, protein carbonyl and oxidation of mito-
chondrial DNA have been observed in the brains of AD
patients [54]. Analysis of AD brains demonstrates an in-
crease in lipid peroxidation products in the amygdala,
hippocampus and parahippocampal gyrus of the AD
brain compared with age-matched controls [55]. Fur-
thermore, it has been reported that many neuropsy-
chiatric/neurodegenerative disorders are associated with
dysregulation of the hypothalamic-pituitary-adrenal (HPA)
axis, as well as with oxidative stress, it is possible that oxi-
dative stress disturbs the HPA-axis function, altering the
level of corticosterone with subsequent effects on hypo-
thalamus and amygdala [56]. Also, other reports have
shown that increased oxidative stress in the hypothalamus
and amygdala can alter the function of fear-related circuits
in the brain. This may play an important role in behavioral
regulation and development of anxiety [57,58].
In our study, Aβ (1–42) alone-treated rats exhibited in-
crease of CAT specific activity, elevated protein carbonyl
and MDA levels and decrease of the total content of re-
duced GSH and GPX specific activity in the amygdala ho-
mogenates. Additionally, the specific activity of SOD in
Aβ(1–42) alone-treated rats exhibited a small decrease as
compared to control rats. The enzymes catalase and SOD
are the major defenses against reactive oxygen species
(ROS). SOD converts superoxide anions into H2O2, and
catalase converts H2O2 to molecular oxygen and water.
SOD exists in two forms: Cu/ZnSOD is present primarily
in the cytoplasm while MnSOD is present primarily in the
mitochondria [59]. Aβ is a metalloprotein that displays a
high affinity binding of Cu2+, Zn2+ and Fe3+ ions [60].
However, since the formation of amyloid plaques is asso-
ciated with metal-mediated Aβ aggregation [61], a possible
explanation for the observed decrease of SOD activity
could be attributed to the perturbation of the brain metals
levels [62]. The brain is a specialized organ that concen-
trates metal ions and changes in brain metals have been
implicated in several neurodegenerative disorders such as
AD [63]. Moreover, since the oxidative stress significantly
increased in Aβ (1–42) alone-treated rats, consequently
the catalase activity intensified. The increase of the CAT
specific activities showed to correspond with the increase
in the protein carbonyl and MDA levels in the amygdala
homogenates suggesting that these events are needed to
scavenge superoxide radicals induced by Aβ (1–42). It has
been suggested that oxidative damage to proteins and
DNA in addition to lipids is an important early event in
the pathogenesis of AD [64]. ROS-mediated reactions
with proteins lead to the formation of protein carbonyl de-
rivative, which serves as a marker of ROS-mediated pro-
tein damage. With this marker, it was established thatoxidative-damaged protein is associated with aging and
AD [65]. The increased protein carbonyl in the AD brain,
together with the altered activities of antioxidant enzymes
(in some cases due to oxidation), coupled with studies
showing that Aβ (1–42)-induced neuronal protein oxida-
tion can be inhibited by antioxidants [66], indicate that
Aβ-induced protein oxidation may account, in part, for
neurodegeneration in the AD brain. MDA level, an index
of lipid peroxidation produced by free radicals, it is the
intermediate product of lipid pigment formation process.
It can indirectly reflect the lipid peroxidation level, leading
to nerve cells damage within the protein metabolism
disorder caused by cell dysfunction [67]. Consistently,
increased lipid peroxidation was observed in an animal
model of Alzheimer amyloidosis [68]. Moreover, both
doses of the methanolic extract 50 and 100 mg/kg (but es-
pecially 100 mg/kg) with high amount of piperine, re-
stored the specific activities of SOD (Figure 4a) and CAT
(Figure 4c) and only 50 mg/kg increased the GPX activity
(Figure 4b) in the amygdala homogenates of Aβ (1–42)-
treated rats. As expected for the antioxidant agents, both
doses of the methanolic extract (50 and 100 mg/kg),
decreased the protein carbonyl (Figure 4e) and MDA
(Figure 4f) levels along with the increase of the total con-
tent of reduced GSH (Figure 4d) in the amygdala homoge-
nates of Aβ (1–42)-treated rats.
Our study support the hypothesis where decreased
SOD and CAT specific activities in Aβ (1–42)-treated
rats treated with the methanolic extract can lead to de-
creased production of intracellular of H2O2 with a sim-
ultaneous increase of GPX activity. This could decrease
the stimulation of lipid peroxidation and protein oxida-
tion, implying that the methanolic extract possesses
strong antioxidant profile.
Additionally, when linear regression was determined, a
significant correlation between the percentage of the time
spent in the open arms vs. MDA, swimming time vs.
MDA, immobility time vs. MDA, SOD vs. MDA, GPX vs.
MDA, CAT vs. MDA and protein carbonyl vs. MDA was
observed. These results may suggest that the increase of
anxiolytic and antidepressant responses within elevated
plus maze and forced swimming test and the antioxidant
defence along with decrease of lipid peroxidation and pro-
tein oxidation could be correlated with involvement of the
methanolic extract in neuroprotection against Aβ (1–42)-
induced oxidative stress generation in the rat amygdala.
Also, we reported the absence of DNA cleavage patterns in
the amygdala of the Aβ (1–42)-treated rats treated with
the methanolic extract, suggesting that the methanolic ex-
tract possesses neuroprotective and antiapoptotic activities.
Conclusions
In summary, the methanolic extract of P. nigrum fruits
has anxiolytic and antidepressant effects, and may confer
Hritcu et al. Behavioral and Brain Functions  (2015) 11:13 Page 12 of 13neuroprotection due to alleviation of oxidative stress
induced by Aβ (1–42) injection in the rat amygdala.
Furthermore, administration of the methanolic extract
might offer a useful alternative or complementary choice
in either the prevention or the treatment of psychiatric
condition close related to AD conditions.
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